Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Remote Ischaemic Preconditioning in the Prevention of Contrast Induced Nephropathy in Patients Undergoing Elective Diagnostic or Therapeutic Peripheral Angiography: a Pilot Randomised Controlled Trial

NCT02516072 is registered in ClinicalTrials.gov with Changi General Hospital as lead sponsor.

NCT NCT02516072
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02516072 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Remote Ischaemic Preconditioning in the Prevention of Contrast Induced Nephropathy in Patients Undergoing Elective Diagnostic or Therapeutic Peripheral Angiography: a Pilot Randomised Controlled Trial
Lead sponsor
Changi General Hospital
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2015
Completion date
September 30, 2018
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

contrast induced nephropathy, remote ischaemic preconditioning